Contributions of SecondarySrc_Seb

Contributions by SecondarySrc_Seb, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 2,766 edits includes activity predating the current log.

1. 03:27, 17 Jul 2026 (diff | hist) Shanghai Sigma-Audley New Material Technology 12,666 ±0 copyedit
2. 20:25, 26 Jun 2026 (diff | hist) Shanghai Sigma-Audley New Material Technology 12,666 ±0 m rm maintenance tag, addressed
3. 00:08, 16 Jun 2026 (diff | hist) Hubei Jianxiang Bioscience 12,122 ±0 m add comparator rate
4. 11:27, 15 Jun 2026 (diff | hist) Bachem Holding (Suzhou) 12,136 ±0 attribute range as a review estimate per talk
5. 08:23, 5 Jun 2026 (diff | hist) Guangzhou JEEP Biotechnology 12,891 ±0 move unsourced paragraph to talk
6. 21:34, 5 May 2026 (diff | hist) Nantong Guangyuan Chemical 12,306 ±0 add {{refimprove}}
7. 12:52, 15 Mar 2026 (diff | hist) Qingdao Saber Technology Pharmaceutical 11,956 ±0 attribute claim in-text
8. 22:44, 2 Mar 2026 (diff | hist) Shanghai ERP Biotechnology 11,516 ±0 attribute claim in-text
9. 23:19, 10 Feb 2026 (diff | hist) Shanghai ERP Biotechnology 11,450 +680 correct transposed digits
10. 13:27, 5 Feb 2026 (diff | hist) Tianjin Finder Chemical 11,889 ±0 attribute claim in-text
11. 05:43, 4 Feb 2026 (diff | hist) Shanghai ERP Biotechnology 10,770 +226 add citation
12. 06:40, 26 Nov 2025 (diff | hist) Shanghai Wibson Biotechnology 10,950 ±0 add PMID
13. 17:48, 9 Nov 2025 (diff | hist) Qingdao Saber Technology Pharmaceutical 8,771 +810 move unsourced paragraph to talk
14. 03:20, 2 Nov 2025 (diff | hist) Sangon Biotech 11,780 ±0 m expand §Independent testing record
15. 21:44, 25 Sep 2025 (diff | hist) Wuhan Wansheng Biotechnology 12,543 +860 add figure
16. 03:10, 9 Sep 2025 (diff | hist) Chinese Peptide Company 12,370 ±0 promote subsection to section
17. 19:12, 4 Sep 2025 (diff | hist) Shanghai ERP Biotechnology 5,568 +74 restructure
18. 13:28, 30 Aug 2025 (diff | hist) Zhuhai Kerui Biotechnology 6,822 ±0 de-orphan
19. 07:26, 4 Aug 2025 (diff | hist) Guangzhou JEEP Biotechnology 11,169 ±0 add confidence interval
20. 14:05, 2 Jul 2025 (diff | hist) ChinaPeptides 9,088 +810 m restructure
21. 12:04, 30 May 2025 (diff | hist) Chinese Peptide Company 10,645 +250 fix significant figures — source gives fewer
22. 09:00, 21 May 2025 (diff | hist) Zhuhai Kerui Biotechnology 1,735 +1,735 N create article
23. 19:25, 8 Apr 2025 (diff | hist) Xi'an Mokemei Biotechnology 2,368 ±0 m split overlong sentence
24. 05:52, 6 Apr 2025 (diff | hist) Hunan Aslsen Technology 7,447 +347 expand §Notability and coverage
25. 15:01, 29 Mar 2025 (diff | hist) Sangon Biotech 6,262 +318 add DOI
26. 19:41, 19 Mar 2025 (diff | hist) Xi'an Mokemei Biotechnology 2,179 ±0 m add DOI
27. 05:15, 25 Feb 2025 (diff | hist) Guangzhou JEEP Biotechnology 8,331 ±0 m add short description
28. 12:13, 9 Jan 2025 (diff | hist) Nantong Guangyuan Chemical 6,634 ±0 m expand §Regulatory position and legal status
29. 15:41, 17 Dec 2024 (diff | hist) Hunan Aslsen Technology 5,176 +342 move unsourced paragraph to talk
30. 09:00, 3 Dec 2024 (diff | hist) Sangon Biotech 1,705 +1,705 N new article — stub, expansion welcome
31. 01:03, 2 Dec 2024 (diff | hist) Hunan Aslsen Technology 4,834 ±0 correct molar mass
32. 00:55, 12 Nov 2024 (diff | hist) ChinaPeptides 2,909 ±0 expand §Regulatory position and legal status
33. 05:10, 29 Oct 2024 (diff | hist) Chinese Peptide Company 4,480 ±0 link to the policy rather than restating it
34. 09:51, 6 Oct 2024 (diff | hist) Karl Fischer titration 4,481 ±0 m attribute range as a review estimate per talk
35. 02:17, 28 Jul 2024 (diff | hist) Guangzhou JEEP Biotechnology 2,747 +38 reorder sections to follow the class template